PELL Bio-Med Technology Co Ltd(TW:6949)
NT$44.75+3.20 (+7.70%)
TW:6949
PELL Bio-Med Technology Co Ltd financials statements
NT$44.75
At close:+3.20 (+7.70%)
PELL Bio-Med Technology Co Ltd (6949) Ratios
PELL Bio-Med Technology Co Ltd Ratios
TW:6949's free cash flow for Q2 2026 was NT$-151.41M. For the 2026 fiscal year, TW:6949's free cash flow was decreased by NT$-23.73M and operating cash flow was NT$-127.68M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.31 | 3.60 | 12.62 | 12.67 | 2.98 |
| Quick Ratio | 4.29 | 3.58 | 12.58 | 12.59 | 2.89 |
| Cash Ratio | 0.99 | 1.33 | 1.88 | 3.01 | 2.62 |
| Solvency Ratio | -0.90 | -0.75 | -1.49 | -0.87 | -0.94 |
| Operating Cash Flow Ratio | -0.91 | -0.81 | -2.02 | -2.72 | -2.46 |
| Short-Term Operating Cash Flow Coverage | -2.81 | -1.30 | 0.00 | -31.14 | -7.88 |
| Net Current Asset Value | NT$ 913.15M | NT$ 699.11M | NT$ 890.27M | NT$ 495.60M | NT$ -37.20M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.21 | 0.12 | 0.19 | 0.36 |
| Debt-to-Equity Ratio | 0.17 | 0.31 | 0.15 | 0.25 | 0.63 |
| Debt-to-Capital Ratio | 0.14 | 0.24 | 0.13 | 0.20 | 0.39 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.49 | 1.48 | 1.21 | 1.30 | 1.75 |
| Debt Service Coverage Ratio | -4.11 | -1.71 | -138.18 | -31.08 | -10.29 |
| Interest Coverage Ratio | -228.53 | -182.96 | -160.89 | -173.48 | -129.09 |
| Debt to Market Cap | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.20 | 0.32 | 0.19 | 0.26 | 0.21 |
| Net Debt to EBITDA | 0.16 | 0.18 | -0.01 | -0.15 | -0.16 |
| Profitability Margins | |||||
| Gross Profit Margin | -13.97% | -62.79% | -144.96% | -246.53% | -247.05% |
| EBIT Margin | -1487.24% | -2001.20% | -2211.46% | -1340.05% | -1341.17% |
| EBITDA Margin | -1337.30% | -1762.96% | -1958.51% | -1159.13% | -1125.38% |
| Operating Profit Margin | -1487.24% | -2106.35% | -2280.52% | -1376.17% | -1402.03% |
| Pretax Profit Margin | -1440.53% | -2012.71% | -2225.02% | -1347.98% | -1352.03% |
| Net Profit Margin | -1349.09% | -1983.67% | -2211.26% | -1341.32% | -1351.93% |
| Continuous Operations Profit Margin | -1440.53% | -2013.28% | -2225.03% | -1347.99% | -1351.93% |
| Net Income Per EBT | 93.65% | 98.56% | 99.38% | 99.51% | 99.99% |
| EBT Per EBIT | 96.86% | 95.55% | 97.57% | 97.95% | 96.43% |
| Return on Assets (ROA) | -20.07% | -22.32% | -28.12% | -22.03% | -47.97% |
| Return on Equity (ROE) | -29.82% | -33.00% | -34.08% | -28.73% | -84.03% |
| Return on Capital Employed (ROCE) | -25.92% | -29.05% | -30.95% | -23.92% | -56.04% |
| Return on Invested Capital (ROIC) | -24.20% | -25.04% | -30.37% | -23.10% | -52.36% |
| Return on Tangible Assets | -20.10% | -22.34% | -28.17% | -22.09% | -48.15% |
| Earnings Yield | -2.11% | -8.34% | -8.37% | -5.70% | -5.51% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.23 | 4.55 | 2.27 | 2.68 | 1.32 |
| Payables Turnover | 6.28 | 7.15 | 6.32 | 10.67 | 15.40 |
| Inventory Turnover | 5.41 | 5.17 | 11.74 | 12.98 | 11.45 |
| Fixed Asset Turnover | 0.04 | 0.04 | 0.07 | 0.06 | 0.06 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.02 | 0.04 |
| Working Capital Turnover Ratio | 0.03 | 0.02 | 0.02 | 0.05 | 0.00 |
| Cash Conversion Cycle | 79.16 | 99.77 | 133.92 | 130.29 | 285.44 |
| Days of Sales Outstanding | 69.83 | 80.19 | 160.61 | 136.37 | 277.26 |
| Days of Inventory Outstanding | 67.46 | 70.61 | 31.09 | 28.12 | 31.88 |
| Days of Payables Outstanding | 58.13 | 51.03 | 57.78 | 34.20 | 23.70 |
| Operating Cycle | 137.29 | 150.80 | 191.70 | 164.48 | 309.14 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.24 | -0.23 | -0.19 | -0.20 | -0.16 |
| Free Cash Flow Per Share | -0.43 | -0.46 | -0.21 | -0.21 | -0.18 |
| Dividend Paid and CapEx Coverage Ratio | -1.24 | -0.99 | -10.92 | -18.33 | -7.50 |
| Capital Expenditure Coverage Ratio | -1.24 | -0.99 | -10.92 | -18.33 | -7.50 |
| Operating Cash Flow Coverage Ratio | -1.18 | -0.71 | -1.04 | -0.77 | -0.77 |
| Operating Cash Flow to Sales Ratio | -8.95 | -13.25 | -9.98 | -9.07 | -7.76 |
| Free Cash Flow Yield | -2.53% | -11.23% | -4.12% | -4.06% | -3.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -47.39 | -12.03 | -11.95 | -17.55 | -18.13 |
| Price-to-Sales (P/S) Ratio | 639.28 | 237.73 | 264.22 | 235.48 | 245.23 |
| Price-to-Book (P/B) Ratio | 14.13 | 3.96 | 4.07 | 5.04 | 15.24 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -39.48 | -8.90 | -24.25 | -24.61 | -27.87 |
| Price-to-Operating Cash Flow Ratio | -71.42 | -17.94 | -26.47 | -25.95 | -31.59 |
| Price-to-Earnings Growth (PEG) Ratio | -7.49 | 0.57 | -0.26 | -5.25 | 0.00 |
| Enterprise Value Multiple | -47.64 | -13.30 | -13.50 | -20.47 | -21.95 |
| Enterprise Value | 20.02B | 4.60B | 4.77B | 4.07B | 3.45B |
| EV to EBITDA | -47.64 | -13.30 | -13.50 | -20.47 | -21.95 |
| EV to Sales | 637.07 | 234.55 | 264.49 | 237.25 | 247.03 |
| EV to Free Cash Flow | -39.34 | -8.79 | -24.28 | -24.79 | -28.07 |
| EV to Operating Cash Flow | -71.17 | -17.70 | -26.50 | -26.15 | -31.82 |
| Tangible Book Value Per Share | 1.44 | 1.13 | 1.27 | 1.03 | 0.34 |
| Shareholders’ Equity Per Share | 1.21 | 1.03 | 1.26 | 1.02 | 0.34 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
| Net Income Per Share | -0.36 | -0.34 | -0.43 | -0.29 | -0.28 |
| Tax Burden | 0.94 | 0.99 | 0.99 | 1.00 | 1.00 |
| Interest Burden | 0.97 | 1.01 | 1.01 | 1.01 | 1.01 |
| Research & Development to Revenue | 8.04 | 13.56 | 13.29 | 8.30 | 9.78 |
| SG&A to Revenue | 6.69 | 6.88 | 8.07 | 4.79 | 3.92 |
| Stock-Based Compensation to Revenue | 2.39 | 3.00 | 7.93 | 2.72 | 1.79 |
| Income Quality | 0.62 | 0.66 | 0.45 | 0.68 | 0.57 |
Currency in TWD
